Navigation Links
Experimental drug shows promise in advanced kidney cancer
Date:9/26/2007

Barcelona, Spain: A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumour fails to respond to the cutting edge therapy.

The study, presented today (Wednesday) at the European Cancer Conference (ECCO 14) in Barcelona, showed that the experimental drug, axitinib, shrank tumours and delayed progression of the disease in a group of patients who are among the toughest to treat.

In the study, scientists gave axitinib to 62 patients whose kidney cancer had spread and who had not benefited from a standard treatment, sorafenib, a targeted therapy designed to disrupt cell division signals in cancer cells and block the tumours ability to form new blood vessels that help it grow. Fourteen of the patients also had been given to no avail another similarly targeted drug, sunitinib, after the sorafenib had failed to work. Axitinib works similarly to the other two but is believed to be more potent.

More than half the patients 51 percent experienced tumour shrinkage and in 23 percent of them the shrinkage is considered significant, said lead investigator Dr Brian I. Rini, an associate professor of medicine at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, USA, and a paid member of the Pfizer scientific advisory board. Preliminary analysis shows the progression-free survival was on average more than 7.7 months. We think these results are impressive because these patients were heavily pre-treated and with drugs thought to be similar to axitinib.

The disease progressed in only 24 percent of patients, which we think is low in this kind of setting, Rini added. The study found the tumour remained stable in 37 percent of the patients.

Historically, metastatic kidney cancer has been very tough to treat, with a median survival of 12 months. Through the results of this trial, it appears that axitinib is a very active drug in renal cell cancer that can benefit a large
'/>"/>

Contact: Emma Ross
rosswrite@mac.com
34-932-308-832
ECCO-the European CanCer Conference
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Experimental treatment for Ebola Virus Shows promising results in mice
2. FDA approves Phase 0 trial which tests experimental drugs on humans
3. Experimental drug to fight flu
4. Experimental SARS Vaccine
5. Experimental vaccine for shingles is effective
6. Experimental Blood Test May Spot Heart Attack Risk, Study Says
7. Five AIDS Patients To Receive Experimental Anti-retroviral Drugs
8. TMC 114 and 125 experimental drugs to be tested on four HIV patients
9. Protection against HIV and Herpes is possible with the Experimental Microbicide
10. Experimental Therapy Effective Against Malignant Melanoma in Horses
11. Experimental Alzheimer’s Drug curbs the disease in mic

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/--Thanksgivingmealswillbedeliveredtoapproximatel...nkstoFaithInAction/VolunteerActionforAging,aprogra...HealthPlan.Formorethan17yearstheseorganizationshav...vingmealstoseniorsinneedinLongBeach,Lakewood,Signa.... ,, "Ourwarmholidaymealsaredeliveredtopeoplewh...
(Date:11/25/2009)...wswire/--TheBlackAIDSInstituterecentlyheldBoardofD...010. ,, ThenewBoardMembersareahighlydiversegrou...e,governmenthealthprograms,editorial,andbusinessen...rsonalbackgroundsincludingbothheterosexualandgayBl...esentingmultipleagegroups. ,, (Photo: http://ww...
(Date:11/25/2009)...ess,andPressJoinEfforttoEducate ,, MEMPHIS,Ten...ionalBipolarFoundationandtheMedicAlertFoundationre...ogram,whichisnowbeingwidelyacceptedasapreventivehe...lBipolarFoundationreceivedaproclamationofendorseme...fLouisianaMitchLandrieu.TheNationalBipolarFoundati...
(Date:11/25/2009)...atistically significant survival benefit from adju...tor (ER)-positive tumors had high levels of phosph...8-P), according to a brief communication published...l Cancer Institute . , Approximately 50% of brea...cal studies have shown that ER-alpha S118-P is req...
(Date:11/25/2009)...his simple question has been the focus of intense ...Modulates High Blood Pressure in Mice & Men, Does...tion has been the focus of intense research for ma... established a link between a novel gene, phosduci...ce as well as humans. The studies were directed by...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ge-old conception that memory capacity is solely d... the brain, a recent research demonstrates that //...increase their capacity to remember what is really...y, does not depend on extra storage space in the b...
...nese city in northeastern China, has suspended dri...ation, fearing possibility of contamination by che..., northeastern China, Tuesday "made a U-turn by ad...ther reports said the city had suspended its publi...
...tals Group is planning expansion of its super-spec...elhi, and bigger units in Kolkata and Bangalore.//...ew hospital at Pitampura (in west Delhi) which wou...he existing 110-bed cardiac care hospital in Banga...
...ines were issued today by the National Institute f...ational Collaborating Centre for Mental Health,// ... obsessive-compulsive disorder (OCD) and body dysm... is characterized by the occurrence of obsessions ...
...ai International Forum on a Healthy City has raise...g specific groups such as young people, specially ...s.// Smoking, which still remains one of the lead...unicipal Center for Disease Prevention and Control...
...ate over the safety of artificial sweeteners got a... Control Council today stated that a rat study con... contradictory with the extensive scientific resea... of aspartame. The study, to be published in Envir...
Other Medicine News:Health News:Wockhardt Group Plans Hospital In Delhi By End-2007 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire-FirstCall/--AnadysPh...titwillpresentatthe21stAnnualPiperJaffrayHealthcar...:00a.m.PST).TheconferenceisbeingheldatTheNewYorkPa...utiveOfficerofAnadys,willprovideanoverviewofAnadys... ,, Thecorporatepresentationwillbesimultaneousl...
(Date:11/24/2009)..., POTOMAC,Md.,Nov.24/PRNewswire/--Inadditiontofam...saddedPhiladelphiajurorstoherThanksgivinggratitude....Iamsothankfultothem,"shesaidofMonday,sverdictstot...ls. ,, Wisneskiisamong12,000womennationwidewhoh...rmonetherapydrugsPremarinandPrempro.Wisneskiandthe...
(Date:11/24/2009)..., SANDIEGO,Nov.24/PRNewswire/--Accumetrics,Inc.,a...174;System,thefirstrapidandeasy-to-usediagnosticsy...tiplateletagents(e.g.Plavix®andaspirin),annou...etrics,andGregoryJ.Tibbitts,ChiefFinancialOfficero...he21stAnnualPiperJaffrayHealthCareConferencebeingh...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Maryland Woman Thankful for Wyeth Verdicts 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Announces Earnings Release Date and Conference Call For Second Quarter 2009 Financial Results 51693 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 1Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 2Michael J Fox Foundation Awards Over 242 Million for Validation of 10 Parkinsons Therapeutic Targets 4724 3Walking Biking to Work Pays Off 51688 1Walking Biking to Work Pays Off 51688 2
... DIEGO, April 13 Researchers from the,Barbara Ann...ted findings,showing that adding curcumin or resve...tive in preventing the growth of chemo-resistant c...ivered at the American Association,for Cancer Rese...ttp://www.newscom.com/cgi-bin/prnh/20071106/KARMAN...
... Gregory Ellison, Director of Advanced Medical Cen...r PROMETA(R), PHOENIX, April 11 With Arizona fac...Gregory Ellison, Director of Advanced Medical,Cent...treatment option that,shows high success rates and...) basis in 10 hours over five sessions. As the onl...
Other Medicine Technology:Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 2Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate 3
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: